Answers are grounded in this paper and cite their sources.
This document provides supplementary guidance on specific topics for the allergenicity risk assessment of genetically modified plants.In particular, it supplements general recommendations outlined in previous EFSA GMO Panel guidelines and Implementing Regulation (EU) No 503/2013.The topics addressed are non-IgE-mediated adverse immune reactions to foods, in vitro protein digestibility tests and endogenous allergenicity.New scientific and regulatory developments regarding these three topics are described in this document.Considerations on the practical implementation of those developments in the risk assessment of genetically modified plants are discussed and recommended, where appropriate.
No takes yet. Share an insight, caveat, or question.
Naegeli et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: